TGT

TGT
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $25.398B ▲ | $5.252B ▼ | $971M ▲ | 3.823% ▲ | $2.1 ▲ | $2.071B ▼ |
| Q2-2025 | $25.211B ▲ | $5.325B ▲ | $935M ▼ | 3.709% ▼ | $2.05 ▼ | $2.111B ▼ |
| Q1-2025 | $23.846B ▼ | $5.184B ▼ | $1.036B ▼ | 4.345% ▲ | $2.28 ▼ | $2.291B ▲ |
| Q4-2024 | $30.915B ▲ | $5.969B ▲ | $1.103B ▲ | 3.568% ▲ | $2.42 ▲ | $2.267B ▲ |
| Q3-2024 | $25.668B | $5.485B | $854M | 3.327% | $1.86 | $1.956B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.822B ▼ | $59.991B ▲ | $44.49B ▲ | $15.501B ▲ |
| Q2-2025 | $4.341B ▲ | $57.851B ▲ | $42.431B ▲ | $15.42B ▲ |
| Q1-2025 | $2.887B ▼ | $56.185B ▼ | $41.238B ▼ | $14.947B ▲ |
| Q4-2024 | $4.762B ▲ | $57.769B ▼ | $43.103B ▼ | $14.666B ▲ |
| Q3-2024 | $3.433B | $58.531B | $44.042B | $14.489B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $971M ▲ | $1.934B ▼ | $-1.089B ▼ | $-552M ▼ | $1.031B ▼ | $807M ▼ |
| Q2-2025 | $935M ▼ | $2.083B ▲ | $-1.066B ▼ | $437M ▲ | $1.454B ▲ | $2.873B ▲ |
| Q1-2025 | $1.036B ▼ | $275M ▼ | $-787M ▲ | $-1.363B ▼ | $-1.875B ▼ | $-515M ▼ |
| Q4-2024 | $1.103B ▲ | $3.289B ▲ | $-918M ▼ | $-1.042B ▼ | $1.329B ▲ | $2.366B ▲ |
| Q3-2024 | $854M | $739M | $-637M | $-166M | $-64M | $84M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Advertising Revenue | $0 ▲ | $650.00M ▲ | $160.00M ▼ | $220.00M ▲ |
Apparel and Accessories | $4.00Bn ▲ | $4.34Bn ▲ | $3.71Bn ▼ | $4.09Bn ▲ |
Beauty | $3.23Bn ▲ | $3.44Bn ▲ | $3.10Bn ▼ | $3.40Bn ▲ |
Beauty and Household Essentials | $4.71Bn ▲ | $4.79Bn ▲ | $4.36Bn ▼ | $4.42Bn ▲ |
Credit Card Profit Sharing | $150.00M ▲ | $140.00M ▼ | $140.00M ▲ | $130.00M ▼ |
Food and Beverage | $5.92Bn ▲ | $6.52Bn ▲ | $5.90Bn ▼ | $5.59Bn ▼ |
Hardlines | $3.15Bn ▲ | $6.15Bn ▲ | $3.07Bn ▼ | $3.52Bn ▲ |
Home Furnishings and Decor | $4.18Bn ▲ | $5.09Bn ▲ | $3.22Bn ▼ | $3.66Bn ▲ |
Other Product | $30.00M ▲ | $100.00M ▲ | $40.00M ▼ | $180.00M ▲ |
Other Other Revenue | $290.00M ▲ | $-300.00M ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Target’s financials show a large, mature retailer that rode a pandemic surge, weathered a profitability setback, and is now back to more stable earnings with moderate growth. The balance sheet and cash flows indicate a willingness to lean into investment and some debt to strengthen its stores, logistics, and digital capabilities, while still keeping overall finances reasonably solid. Competitively, Target’s blend of brand appeal, omnichannel convenience, and strong private labels provides meaningful differentiation, though it must continually defend that ground against powerful rivals. Its ongoing focus on technology, AI, loyalty programs, and curated product experiences positions it to adapt as retail evolves, but execution quality and consumer spending trends will be critical swing factors for future performance.
NEWS
November 28, 2025 · 5:00 PM UTC
Royal Helium Ltd. Announces Exit and Closing of CCAA Transaction
Read more
November 28, 2025 · 9:01 AM UTC
Guests Can Shop Cyber Monday Savings at Target Like Never Before Using AI and New Digital Features
Read more
November 25, 2025 · 12:00 PM UTC
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
Read more
November 24, 2025 · 3:10 AM UTC
Snowline Gold Drills 534.5 Metres of 0.62 Grams Per Tonne Gold Along Northern Edge of Its Valley Deposit and Intersects RIRGS Mineralization at Gracie Target, Rogue Project, Yukon
Read more
November 20, 2025 · 8:15 AM UTC
Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Read more
About Target Corporation
https://corporate.target.comTarget Corporation operates as a general merchandise retailer in the United States. The company offers food assortments, including perishables, dry grocery, dairy, and frozen items; apparel, accessories, home décor products, electronics, toys, seasonal offerings, food, and other merchandise; and beauty and household essentials.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $25.398B ▲ | $5.252B ▼ | $971M ▲ | 3.823% ▲ | $2.1 ▲ | $2.071B ▼ |
| Q2-2025 | $25.211B ▲ | $5.325B ▲ | $935M ▼ | 3.709% ▼ | $2.05 ▼ | $2.111B ▼ |
| Q1-2025 | $23.846B ▼ | $5.184B ▼ | $1.036B ▼ | 4.345% ▲ | $2.28 ▼ | $2.291B ▲ |
| Q4-2024 | $30.915B ▲ | $5.969B ▲ | $1.103B ▲ | 3.568% ▲ | $2.42 ▲ | $2.267B ▲ |
| Q3-2024 | $25.668B | $5.485B | $854M | 3.327% | $1.86 | $1.956B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.822B ▼ | $59.991B ▲ | $44.49B ▲ | $15.501B ▲ |
| Q2-2025 | $4.341B ▲ | $57.851B ▲ | $42.431B ▲ | $15.42B ▲ |
| Q1-2025 | $2.887B ▼ | $56.185B ▼ | $41.238B ▼ | $14.947B ▲ |
| Q4-2024 | $4.762B ▲ | $57.769B ▼ | $43.103B ▼ | $14.666B ▲ |
| Q3-2024 | $3.433B | $58.531B | $44.042B | $14.489B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $971M ▲ | $1.934B ▼ | $-1.089B ▼ | $-552M ▼ | $1.031B ▼ | $807M ▼ |
| Q2-2025 | $935M ▼ | $2.083B ▲ | $-1.066B ▼ | $437M ▲ | $1.454B ▲ | $2.873B ▲ |
| Q1-2025 | $1.036B ▼ | $275M ▼ | $-787M ▲ | $-1.363B ▼ | $-1.875B ▼ | $-515M ▼ |
| Q4-2024 | $1.103B ▲ | $3.289B ▲ | $-918M ▼ | $-1.042B ▼ | $1.329B ▲ | $2.366B ▲ |
| Q3-2024 | $854M | $739M | $-637M | $-166M | $-64M | $84M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Advertising Revenue | $0 ▲ | $650.00M ▲ | $160.00M ▼ | $220.00M ▲ |
Apparel and Accessories | $4.00Bn ▲ | $4.34Bn ▲ | $3.71Bn ▼ | $4.09Bn ▲ |
Beauty | $3.23Bn ▲ | $3.44Bn ▲ | $3.10Bn ▼ | $3.40Bn ▲ |
Beauty and Household Essentials | $4.71Bn ▲ | $4.79Bn ▲ | $4.36Bn ▼ | $4.42Bn ▲ |
Credit Card Profit Sharing | $150.00M ▲ | $140.00M ▼ | $140.00M ▲ | $130.00M ▼ |
Food and Beverage | $5.92Bn ▲ | $6.52Bn ▲ | $5.90Bn ▼ | $5.59Bn ▼ |
Hardlines | $3.15Bn ▲ | $6.15Bn ▲ | $3.07Bn ▼ | $3.52Bn ▲ |
Home Furnishings and Decor | $4.18Bn ▲ | $5.09Bn ▲ | $3.22Bn ▼ | $3.66Bn ▲ |
Other Product | $30.00M ▲ | $100.00M ▲ | $40.00M ▼ | $180.00M ▲ |
Other Other Revenue | $290.00M ▲ | $-300.00M ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Target’s financials show a large, mature retailer that rode a pandemic surge, weathered a profitability setback, and is now back to more stable earnings with moderate growth. The balance sheet and cash flows indicate a willingness to lean into investment and some debt to strengthen its stores, logistics, and digital capabilities, while still keeping overall finances reasonably solid. Competitively, Target’s blend of brand appeal, omnichannel convenience, and strong private labels provides meaningful differentiation, though it must continually defend that ground against powerful rivals. Its ongoing focus on technology, AI, loyalty programs, and curated product experiences positions it to adapt as retail evolves, but execution quality and consumer spending trends will be critical swing factors for future performance.
NEWS
November 28, 2025 · 5:00 PM UTC
Royal Helium Ltd. Announces Exit and Closing of CCAA Transaction
Read more
November 28, 2025 · 9:01 AM UTC
Guests Can Shop Cyber Monday Savings at Target Like Never Before Using AI and New Digital Features
Read more
November 25, 2025 · 12:00 PM UTC
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
Read more
November 24, 2025 · 3:10 AM UTC
Snowline Gold Drills 534.5 Metres of 0.62 Grams Per Tonne Gold Along Northern Edge of Its Valley Deposit and Intersects RIRGS Mineralization at Gracie Target, Rogue Project, Yukon
Read more
November 20, 2025 · 8:15 AM UTC
Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Read more

CEO
Brian C. Cornell
Compensation Summary
(Year 2024)

CEO
Brian C. Cornell
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2000-07-20 | Forward | 2:1 |
| 1998-05-01 | Forward | 2:1 |
| 1996-07-18 | Forward | 3:1 |
| 1983-07-25 | Forward | 2:1 |
| 1981-12-01 | Forward | 2:1 |
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades

DA Davidson
Buy

UBS
Buy

Guggenheim
Buy

Jefferies
Buy

RBC Capital
Outperform

Oppenheimer
Outperform

Wells Fargo
Overweight

Morgan Stanley
Overweight

Telsey Advisory Group
Market Perform

BMO Capital
Market Perform

Evercore ISI Group
In Line

JP Morgan
Neutral

Citigroup
Neutral

Mizuho
Neutral

Goldman Sachs
Neutral

Piper Sandler
Neutral

Roth MKM
Neutral

Truist Securities
Hold

Stifel
Hold

Barclays
Underweight

Bernstein
Underperform

B of A Securities
Underperform
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
57.926M Shares
$5.25B

STATE STREET CORP
37.648M Shares
$3.412B

BLACKROCK, INC.
34.874M Shares
$3.16B

BLACKROCK INC.
32.409M Shares
$2.937B

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
17.136M Shares
$1.553B

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
16.504M Shares
$1.496B

FMR LLC
14.39M Shares
$1.304B

GEODE CAPITAL MANAGEMENT, LLC
10.29M Shares
$932.52M

BLACKROCK FUND ADVISORS
8.717M Shares
$789.936M

MORGAN STANLEY
8.2M Shares
$743.165M

BLACKROCK GROUP LTD
6.216M Shares
$563.28M

FRANKLIN RESOURCES INC
6.052M Shares
$548.418M

NORGES BANK
5.859M Shares
$530.989M

LEHMAN BROTHERS HOLDINGS INC. PLAN TRUST
5.826M Shares
$528.001M

BANK OF AMERICA CORP /DE/
5.519M Shares
$500.154M

NORTHERN TRUST CORP
5.067M Shares
$459.207M

DIMENSIONAL FUND ADVISORS LP
5.051M Shares
$457.761M

AMERICAN CENTURY INVESTMENT MANAGEMENT INC
4.789M Shares
$433.96M

CAPITAL WORLD INVESTORS
4.587M Shares
$415.683M

WELLS FARGO & COMPANY/MN
4.108M Shares
$372.243M
Summary
Only Showing The Top 20






